Our Technology
ChemoTech have developed a new patented treatment technology platform called TSE – Tumour Specific Electroporation™
ChemoTech have developed a new patented treatment technology platform called TSE – Tumour Specific Electroporation™
Tumour Specific Electroporation™ (TSE) is Neems Hill’s patented electroporation technology platform for cancer treatment. TSE is designed to deliver controlled electrical stimulation to the tumour area, temporarily increasing cell-membrane permeability and supporting increased local uptake of anti-cancer drugs.
Unlike approaches designed to ablate or immediately destroy tissue, TSE is intended to limit unnecessary necrosis and preserve surrounding healthy tissue. The system adapts energy delivery to the electrical characteristics of the treated tissue, enabling controlled treatment across different tumour conditions.
ChemoTech continues to develop the TSE platform in collaboration with physicians, researchers and clinical institutions, with the objective of expanding its use in selected superficial and deep-seated tumours.
Read more about our patentsElectroporation uses short electrical pulses to temporarily increase the permeability of cell membranes. TSE combines this principle with tumour-specific energy control to enhance the uptake of anti-cancer drugs within the treated area.
The technology is designed to balance effective electrical stimulation with reduced tissue destruction, supporting treatment in anatomical areas where preservation of surrounding healthy tissue is particularly important.
Get in touch
Are you interested in our products?
Our team is here to help with any questions about our products, patents or anything else you may need help with.
This website uses cookies. If you continue to browse the website, you agree to the use of cookies.